MAPK3 and hepatocellular carcinoma: The levels of phosphorylation of ERK and P38 expression decreased in HCC, which indicated that inhibition of UBC9 increased the sensitivity of chemotherapeutic drugs through inhibition of the ERK1/2-MAPK and P38-MAPK cell pathways.